PepFinder
guanylate cyclase agonistTherapeutic Peptides

Linaclotide (Linzess)

A 14-amino acid peptide that activates guanylate cyclase-C receptors. FDA-approved for IBS-C and chronic idiopathic constipation. Reduces visceral pain signaling in addition to promoting fluid secretion.

constipationIBS-treatmentvisceral-painFDA-approved
3D Structure
3D Structure
1526.74 Da
Molecular Weight1,526.74 Da
PubChem CID16158208
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
Intensity764960115613521548m/z1526.4
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity data
Lab Reports
0 reports on file
Summary

A 14-amino acid peptide that activates guanylate cyclase-C receptors. FDA-approved for IBS-C and chronic idiopathic constipation. Reduces visceral pain signaling in addition to promoting fluid secreti…